ArticleBMC cancer2018

EP3 (prostaglandin E2 receptor 3) expression is a prognostic factor for progression-free and overall survival in sporadic breast cancer.

Anna Semmlinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.